Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 12, 2019
Context: This filing announces the scheduled release of financial results for the fourth quarter and full year ended December 31, 2018.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notice of the upcoming earnings release.
Material Changes
No material changes to financial performance are reported in this document. The filing indicates that the company expects to report results for the period ended December 31, 2018, but does not disclose the figures or compare them to prior periods.
Guidance, Outlook, and Management Commentary
- Earnings Release Date: After 5:00 PM ET on Tuesday, February 26, 2019.
- Conference Call: Scheduled for Wednesday, February 27, 2019, to discuss fourth quarter and full year 2018 results.
- Exhibits: A press release dated February 12, 2019, is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the actual financial results released on or after February 26, 2019.
- Review the conference call transcript from February 27, 2019, for management commentary on 2018 performance.
- Confirm the specific revenue and net income figures for Q4 and full-year 2018 once the official earnings release is published.